Rifabutin and agranulocytosis Patient Reports February 11, 2012



Rifabutin Side Effects Report #4549583-1
Rifabutin side effect was reported by a Physician from on Dec 27, 2004. Female patient, 50 years of age, was diagnosed with ill-defined disorder and was treated with Rifabutin. After drug was administered, patient experienced the following side effects: agranulocytosis, condition aggravated, haemoglobin decreased, thrombocytopenia. Rifabutin dosage: 450 MG (150 MG, TID), ORAL. During the same period patient was treated with CIPROFLOXACIN, ETHAMBUTOL DIHYDROCHLORIDE, CLARITHROMYCIN, KALETRA, STAVUDINE, LAMIVUDINE. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Rifabutin